Announcements

Announcements

 

Paul G. Allen Frontiers Group [to 15 Aug 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 15 Aug 2020]
https://www.phe.gov/about/barda/Pages/default.aspx
BARDA News
August 11, 2020: Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine
[See Milestones above for detail]

 

BMGF – Gates Foundation [to 15 Aug 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 15 Aug 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 15 Aug 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
08.11.2020  |
CARB-X is funding Evotec to develop a new class of broad-spectrum antibiotics to treat multidrug-resistant bacterial infections
CARB-X is awarding up to US$2.91 million to Evotec SE, a drug discovery and development company headquartered in Hamburg, Germany, to develop a new class of antibiotics to treat infections caused by deadly multidrug-resistant Gram-positive and Gram-negative bacteria. Evotec will be eligible for an additional $5.53 million in non-dilutive funding from CARB-X if project milestones are met, subject to available funds.

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 15 Aug 2020]
http://cepi.net/
Latest News
CEPI reserves manufacturing capacity for COVID-19 vaccines at SK bioscience
13 Aug 2020
[See Milestones above for detail]

 

EDCTP [to 15 Aug 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
14 August 2020
Annual Report 2019 – steering a portfolio for impact

 

Emory Vaccine Center [to 15 Aug 2020]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Medicines Agency [to 15 Aug 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
No new digest content identified.

 

European Vaccine Initiative [to 15 Aug 2020]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

 

FDA [to 15 Aug 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
August 15, 2020 – Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing

August 14, 2020 – Coronavirus (COVID-19) Update: Daily Roundup August 14, 2020

August 13, 2020 – Coronavirus (COVID-19) Update: Daily Roundup August 13, 2020

August 12, 2020 – Coronavirus (COVID-19) Update: Daily Roundup August 12, 2020

August 11, 2020 – Coronavirus (COVID-19) Update: Daily Roundup August 11, 2020

August 10, 2020 – Coronavirus (COVID-19) Update: Daily Roundup August 10, 2020

 

Fondation Merieux [to 15 Aug 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

 

Gavi [to 15 Aug 2020]
https://www.gavi.org/
News releases
No new digest content identified.

 

GHIT Fund [to 15 Aug 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

 

Global Fund [to 15 Aug 2020]
https://www.theglobalfund.org/en/news/
News/Updates
Updates
Country Coordinating Mechanism Evolution: Implementation
12 August 2020

News
Global Fund Launches Search for Inspector General
10 August 2020
The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched a search for its next Inspector General.

 

Hilleman Laboratories [to 15 Aug 2020]
http://www.hillemanlabs.org/
No new digest content identified.

 

Human Vaccines Project [to 15 Aug 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Release
No new digest content identified.

 

IAVI [to 15 Aug 2020]
https://www.iavi.org/newsroom
Features
August 10, 2020
Expanding access to monoclonal antibody-based products: A global call to action
A roadmap to making monoclonal antibodies, one of the most powerful tools in modern medicine, affordable and available to all.
… IAVI has teamed with Wellcome, the independent global charitable foundation, to produce a call to action entitled Expanding Access to Monoclonal Antibody-based Products.
The call to action asks global health stakeholders, both public and private, to make four parallel and vital commitments to ensure equitable access to mAbs:
:: Increase awareness that mAbs save lives and need to be more affordable and widely available.
:: Facilitate broader licensure of mAbs across the globe.
:: Invest in and apply new technologies to lower mAb production and development costs.
:: Create new business models to enable innovative market approaches that promote global access.
…IAVI and Wellcome will launch a series of webinars, virtual meetings, and publications to engage key stakeholders in taking concrete actions to make the recommendations in the report a reality…

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Announcements
No new digest content identified.

 

IFRC [to 15 Aug 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Lebanon
Beirut Explosion: Urgent relief for survivors underway as IFRC appeals for 20 million Swiss francs
Geneva, 9 August 2020 – The International Federation of Red Cross and Red Crescent Societies (IFRC) appealed today for 20 million Swiss francs (US$ 21.8 million dollars) to rapidly scale up emergency medical support and economic relief for survivors of …
9 August 20

 

IRC International Rescue Committee [to 15 Aug 2020]
http://www.rescue.org/press-release-index
Media highlights
Press Release
As COVID cases hit 20M, David Miliband, President and CEO of the IRC, raises alarm on growing numbers in fragile contexts
August 10, 2020

 

IVAC [to 15 Aug 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.

 

IVI [to 15 Aug 2020]
http://www.ivi.int/
Selected IVI News & Announcements
Honoring a life-long advocate for vaccine science and equity
[Undated]

Gordon Dougan, professor in the Department of Medicine at Cambridge University and IVI Board Member, awarded the 2020 Albert B. Sabin Gold Medal
…George Bickerstaff, Chairperson of IVI’s Board of Trustees, congratulated Dougan on his award: “Gordon’s receipt of the Sabin Gold Medal is an outstanding and highly deserved recognition of a true innovator in vaccinology. His contributions will continue to shape vaccine development and delivery, and we at IVI are incredibly fortunate to have his expertise in vaccine science and global health on our Board.”…

 

JEE Alliance [to 15 Aug 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 15 Aug 2020]
http://www.msf.org/
Latest [Selected Announcements]
Lebanon
MSF provides medical and mental health support to Beirut’s most affected communities
Project Update 12 Aug 2020

Coronavirus COVID-19 pandemic
RESPONDING TO COVID-19: Global Accountability Report – March to May 2020
Report 10 Aug 2020
This report is the fi rst in a series of accountability reports and operational snapshots offering insight into MSF’s global COVID-19 response, highlighting activities and outcomes, documenting expenditures, and shedding light on challenges faced in accessing and supplying communities with essential medicines and supplies.

Iraq
Yazidi community suffers one crisis after another
Project Update 9 Aug 2020

 

National Vaccine Program Office – U.S. HHS [to 15 Aug 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC Meetings
September 23-24, 2020 Meeting (Virtual)
February 4-5, 2021 NVAC Meeting
June 16-17, 2021 NVAC Meeting

 

NIH [to 15 Aug 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling
August 10, 2020 — Phase 3 trials conducted in the NIAID COVID-19 Prevention Network.
Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults at clinical trial sites in the United States. Many of the trial sites and study investigators are part of the COVID-19 Prevention Network(link is external) (CoVPN), recently established by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). The trials are enrolling adults who are at risk of infection due to close contact at work or home to persons with SARS-CoV-2 infection.
“The COVID-19 Prevention Network is designed to conduct large-scale trials rapidly and efficiently,” said NIAID Director Anthony S. Fauci, M.D. “This network will allow us to test the safety and efficacy of monoclonal antibodies and other preventive measures to help identify how best to reduce the level of SARS-CoV-2 infection and ultimately end the COVID-19 pandemic.”…

 

PATH [to 15 Aug 2020]
https://www.path.org/media-center/
No new digest content identified.

 

Sabin Vaccine Institute [to 15 Aug 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal; Sabin Vaccine Institute’s New Rising Star Award Presented to Dr. Katherine E. Gallagher
August 13, 2020
Sabin today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge. Sabin also presented the inaugural Rising Star Award to Katherine E. Gallagher, MSc, PhD, assistant professor of epidemiology at the London School of Hygiene and Tropical Medicine.
The Gold Medal, now in its 27th year, is Sabin’s highest scientific honor, given each year to a distinguished member of the global health community who has made extraordinary contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. D.A. Henderson, Maurice Hilleman, Anne Gershon, Myron Levine and Paul Offit…

 

UNAIDS [to 15 Aug 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
11 August 2020
Strengthening the role of faith-based organizations in the HIV response

 

UNICEF [to 15 Aug 2020]
https://www.unicef.org/media/press-releases
Selected Press releases/Announcements
Statement
08/14/2020
UNICEF statement on the situation of children in Belarus
Statement by UNICEF Regional Director for Europe and Central Asia, Ms. Afshan Khan

Press release
08/14/2020
UNICEF appeals for $46.7 million dollars to reach 100,000 children affected by Beirut explosions over the next three months
Geneva Palais briefing note on latest situation for children affected by Beirut explosions and UNICEF response

Press release
08/13/2020
2 in 5 schools around the world lacked basic handwashing facilities prior to COVID-19 pandemic — UNICEF, WHO

Statement
08/12/2020
Eight children die in Al Hol camp, northeastern Syria in less than a week
Statement by UNICEF Executive Director Henrietta Fore

Press release
08/11/2020
UNICEF provides assistance to 40,000 people displaced by inter-ethnic violence in the South Kivu highlands, DRC

Press release
08/11/2020
Polio vaccination campaigns resume in Afghanistan and Pakistan after COVID-19 disruptions leave 50 million children unimmunized
[See Milestones above for detail]

Press release
08/11/2020
Geneva Palais Briefing on children affected by Beirut explosions and UNICEF response

Press release
08/10/2020
Remarks by UNICEF Executive Director Henrietta Fore at the virtual briefing on the humanitarian situation in Lebanon
Prepared remarks – check against delivery

 

Unitaid [to 15 Aug 2020]
https://unitaid.org/
Featured News
No new digest content identified.

 

Vaccination Acceptance Research Network (VARN) [to 15 Aug 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 15 Aug 2020]
http://www.vaccineconfidence.org/
Research and Reports
No new digest content identified.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 15 Aug 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

 

Wellcome Trust [to 15 Aug 2020]
https://wellcome.ac.uk/news
No new digest content identified.

 

The Wistar Institute [to 15 Aug 2020]
https://www.wistar.org/news/press-releases
Press Releases
Aug. 10, 2020
Breast Cancer Cells Use Message-carrying Vesicles to Send Oncogenic Stimuli to Neighboring Normal Cells 
Pro-tumorigenic messages reprogram mitochondrial function in normal cells to promote migration and invasion.

 

WFPHA: World Federation of Public Health Associations [to 15 Aug 2020]
https://www.wfpha.org/
Latest News
No new digest content identified.

 

World Organisation for Animal Health (OIE) [to 15 Aug 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 15 Aug 2020]
https://alliancerm.org/press-releases/
Press Releases
No new digest content identified.

 

BIO [to 15 Aug 2020]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 15 Aug 2020]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 15 Aug 2020]
https://internationalbiotech.org/
News
No new digest content identified.

 

IFPMA [to 15 Aug 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.

 

PhRMA [to 15 Aug 2020]
http://www.phrma.org/
Selected Press Releases, Statements
Press Release
Supporting access to vaccines for Part D beneficiaries
Tom Wilbur   |     August 12, 2020
Today, in honor of National Immunization Awareness Month, we’ll take a look at how Medicare Part D supports access to critical vaccines and strengthens public health. Vaccines represent some of the most impactful advances in public health, helping to prevent the spread of many infectious diseases. Here in the United States, there are currently 16 diseases that are now preventable as a result of childhood vaccines.

A recent report found that there are nearly 260 vaccines in development by America’s biopharmaceutical companies, including dozens for COVID-19 in the pipeline. Biopharmaceutical companies are exploring a wide range of approaches to COVID-19 for older adults including increasing the doses or adding a booster to the shot. Yet no matter the approach, biopharmaceutical researchers must comply with a number of regulations throughout the development process to help ensure vaccine safety.

Continued progress in the research and development of new vaccines is important news for Americans of all ages, but especially for seniors. It is important for adults and seniors to receive certain vaccinations as they age to avoid a variety of serious conditions. The immune system naturally weakens over a patient’s lifespan and vaccines can be critical to prevent illness among the elderly, who may be particularly vulnerable to infection. For example, shingles is caused by the same virus that causes chickenpox (varicella-zoster) and can occur in adults who had chickenpox as children. It is thought that lowered immunity to infections as people grow older may be the cause.

Ensuring greater uptake of and access to vaccines will improve public health and reduce broader health care costs over time. Increasing awareness of the availability and value of vaccines, particularly among adults, can help improve vaccine rates. It is also important to provide robust insurance coverage for preventative care more broadly, including vaccines, in order to avoid vaccine-preventable diseases.

Low adult immunization rates are due to multiple barriers, including lack of information about recommended vaccines, financial hurdles, as well as technological and logistical obstacles.

For medically necessary, commercially available adult vaccines not covered under Medicare Part B, Part D covers available vaccines and, since 2012, the Centers for Medicare & Medicaid Services (CMS) has encouraged Part D plans to offer either $0 or low-cost sharing for vaccines to help increase adult immunization rates. Despite this encouragement, Part D plans continue to apply cost-sharing for vaccines that may limit access for beneficiaries. This effort to ensure vaccines are affordable and accessible to seniors is critical as illnesses attributed to vaccine-preventable diseases remains higher in adults than children…